In a prognostic analysis, high expression of mRNA of both Notch3 and GSK3β was related to better RFS in all patients with breast cancer studied, which implies that Notch3 and GSK3β are beneficial biomarkers in this disease. This evidence concerns the gene GSK3B and breast cancer.